Utilidad de la cirugía espinal mínimamente invasiva en el manejo de las metástasis espinales toraco-lumbares

OBJECTIVE: To describe the surgical results and evolution of patients who underwent minimally invasive spine surgery (MISS) for the treatment of thoracolumbar spinal metastases, using the NOMS (Neurological, Oncological, Mechanical, Systemic) assessment for the therapeutic decision. METHODS: Patients who underwent MISS technique for the treatment of thoracolumbar spinal metastases were prospectively enrolled at the Hospital Italiano de Buenos Aires, from June 2014 to June 2017. In all cases, the NOMS assessments were performed for therapeutic decision making. Surgical results were analyzed in terms of improvements in Karnofsky performance status, pain relief (VAS – visual analog scale), Frankel, blood loss, need for transfusions, complications, use of opioids and hospitalization length. A P < 0.05 value was considered statistically significant. RESULTS: During the study period 26 patients were included, 13 of them were women. The average age was 57-year-old (27–83 years). Breast cancer was the most frequent primary tumor (27%). The main symptom was pain (96%), although 12 patients presented with myelopathy (46%). High-grade epidural spinal cord compression requiring decompression was observed in 17 cases (65%). According to the SINS (spinal instability neoplastic score), most lesions were potentially unstable or unstable (89%) requiring MISS stabilization. After surgery, pain relief (VAS) and neurological recovery (Frankel) improved significantly in the 77% and 67% of the cases, respectively, with low intraoperative blood loss and without any transfusions. Only one minor surgical complication was presented (4%). The average of hospital stay was 5.5 days. CONCLUSION: In our series and using the NOMS as a therapeutic algorithm, MISS was effective for decompression and spinal stabilization, with a low rate of complications and rapid postoperative recovery.